Key result
Transcutaneous auricular Vagus Nerve Stimulation regulates the autonomic nervous system and may be a safer alternative to invasive stimulation for treatment-resistant mood disorders.
Why the study?
Transcutaneous auricular Vagus Nerve Stimulation may be a safer alternative to invasive stimulation, but a systematic review of its efficacy and safety in depressive disorders and autonomic regulation was needed.
Does transcutaneous auricular Vagus Nerve Stimulation (taVNS) improve outcomes in patients with depressive disorders and autonomic dysregulation?
Does transcutaneous auricular Vagus Nerve Stimulation (taVNS) improve outcomes in patients with depressive disorders and autonomic dysregulation?
taVNS is a promising noninvasive neuromodulation method that may improve autonomic regulation and serve as an alternative to invasive vagal nerve stimulation for mood disorders, though standardized parameters are needed.
May support taVNS for autonomic dysregulation in depression; leaves open standardized protocols and outcome confirmation in trials.
BACKGROUND: Transcutaneous auricular Vagus Nerve Stimulation (taVNS) is a noninvasive technique that activates vagal projections in the brain and brainstem by stimulating the auricular branch of the vagus nerve. taVNS may be a safer alternative to invasive vagal nerve stimulation for treating treatment-resistant mood disorders, chronic pain, inflammation, cardiovascular dysfunction, inflammatory bowel disease, and Crohn's disease. OBJECTIVE: This study aims to systematically review the current evidence on the efficacy and safety of taVNS in treating depressive disorders and its modulatory effects on the autonomic nervous system. METHODS: Relevant primary and secondary sources were identified through a systematic search of the PubMed and Google Scholar databases from 2008 to 2023. The review used the Scale for Assessment of Narrative Review Articles, resulting in a 0.77% intraclass correlation coefficient, 95% CI, and 0.88 inter-rater reliability. RESULTS: taVNS, a new noninvasive neuromodulation method, stimulates the auricular branch of the vagus nerve and regulates the sympathetic and parasympathetic branches of the ANS, increasing norepinephrine secretion, vagus nerve stimulation adaptability, and heart rate variability. Future studies should clarify the mechanisms and address inconsistencies in taVNS parameters. Standardizing treatment regimens can establish taVNS as a viable, noninvasive treatment. CONCLUSION: Our findings suggest that taVNS may be a safer alternative to invasive vagal nerve stimulation for treatment-resistant mood disorders, chronic pain, inflammation, cardiovascular dysfunction, inflammatory bowel disease, and Crohn's disease. However, further empirical research is needed to elucidate the mechanisms and resolve inconsistencies in the stimulation parameters, and larger studies are required to confirm taVNS as an effective noninvasive treatment.
No takes yet. Share an insight, caveat, or question.
Croft et al. (2025) conducted a review in Mood disorders and autonomic regulation. Transcutaneous auricular Vagus Nerve Stimulation (taVNS) was evaluated on Efficacy and safety in treating depressive disorders and modulatory effects on the autonomic nervous system. Transcutaneous auricular Vagus Nerve Stimulation regulates the autonomic nervous system and may be a safer alternative to invasive stimulation for treatment-resistant mood disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: